Therefore, comparative downregulation of DNAM-1, NKp46, and CD161 on tissue-infiltrated T cells may compromise their functional properties to induce the immune system and anti-tumor potential in ovarian cancer. The gene discussed is CD226; the disease is ovarian cancer.